Immune to Cancer: The CRI Blog
-
Partner Spotlight: Rafael Amado, Adaptimmune
We introduce you to Rafael Amado, MD, chief medical officer at Adaptimmune, a leader in T cell…
-
Connecting and learning about immunotherapy in San Francisco
On June 30, 2018, over 200 patients, caregivers, and advocates gathered to connect with experts and learn…
-
30 Days of CRI Impact: How Bacteria and Vaccines Can Help the Immune System Fight Cancer
This week’s breakthroughs highlight the benefits of bacteria, vaccines, and the use of immunotherapy earlier in the…
-
Bikes, Beers, and One Cause to Cure All Cancers
On June 26, 2018, 48 cyclists—CRI Associate Board members, family, and friends—biked together at SWERVE Fitness Flatiron…
-
Team Cycling for the Answer to Cancer
On June 21, 2018, 60 employees from the Mitsubishi UFJ Financial Group participated in a team-based studio…
-
30 Days of CRI Impact: Getting to Know Your Cancer-Fighting Immune Cells
This week’s CRI-funded breakthroughs highlight the anti-tumor capabilities of T cells, macrophages, and natural killer cells.
-
Taking #WearWhite Day to a Whole New Level
Several CRI staffers headed down to Maryland to participate in a celebratory #WearWhite Day employee engagement event hosted…
-
Lessons on Talking to Your Oncologist About Cancer Immunotherapy
A patient advocate and oncologist discuss the need for trust and communication throughout an immunotherapy clinical trial.
-
Hiking the Appalachian Trail for Cancer Research: A Q&A with Dan Harris
As a survivor of two bouts of cancer—testicular and lung—and having lost friends to the disease, Dan…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.